British Patient Capital invests in a diversified portfolio of best-in-class venture and growth capital funds, capturing value through financing the growth of innovative companies. We invest on a commercial basis to deliver competitive returns and manage risk.

We manage a £2.5bn investment programme designed to unlock an additional £5bn of institutional capital to support UK businesses with high growth potential to access the long-term financing they need to scale up.

As well as providing our own funding we work to encourage more investors to make allocations to this asset class by demonstrating that a long-term patient capital investment strategy can produce commercially attractive returns.

Once we’ve established a strong record, and have proved the value of the asset class, we intend to privatise British Patient Capital at an appropriate time in the future.